TY - JOUR
T1 - Activation of NK cell cytotoxicity
AU - Smyth, Mark J.
AU - Cretney, Erika
AU - Kelly, Janice M.
AU - Westwood, Jennifer A.
AU - Street, Shayna E.A.
AU - Yagita, Hideo
AU - Takeda, Kazuyoshi
AU - Dommelen, Serani L.H.Van
AU - Degli-Esposti, Mariapia A.
AU - Hayakawa, Yoshihiro
N1 - Funding Information:
We thank Joe Trapani for helpful discussions. Work in our laboratories was supported by a Cancer Research Institute Post-Doctoral Fellowship to YH, an Melbourne Research Scholarship to EC, a Human Frontiers Science Program research grant to MJS and HY, National Health and Medical Research Council of Australia Project Grants to MJS and MAD-E, a Program Grant to MJS, a Dora Lush Postgraduate Award to SEAS and a Research Fellowship to MJS. MAD-E is supported by a Wellcome Trust Overseas Senior Research Fellowship in Biomedical Science. Apologies to authors of papers we were unable to cite because of space restrictions.
PY - 2005/2
Y1 - 2005/2
N2 - Natural killer (NK) cells are innate effector lymphocytes necessary for defence against stressed, microbe-infected, or malignant cells. NK cells kill target cells by either of two major mechanisms that require direct contact between NK cells and target cells. In the first pathway, cytoplasmic granule toxins, predominantly a membrane-disrupting protein known as perforin, and a family of structurally related serine proteases (granzymes) with various substrate specificities, are secreted by exocytosis and together induce apoptosis of the target cell. The granule-exocytosis pathway potently activates cell-death mechanisms that operate through the activation of apoptotic cysteine proteases (caspases), but can also cause cell death in the absence of activated caspases. The second pathway involves the engagement of death receptors (e.g. Fas/CD95) on target cells by their cognate ligands (e.g. FasL) on NK cells, resulting in classical caspase-dependent apoptosis. The comparative role of these pathways in the pathophysiology of many diseases is being dissected by analyses of gene-targeted mice that lack these molecules, and humans who have genetic mutations affecting these pathways. We are also now learning that the effector function of NK cells is controlled by interactions involving specific NK cell receptors and their cognate ligands, either on target cells, or other cells of the immune system. This review will discuss the functional importance of NK cell cytotoxicity and the receptor/ligand interactions that control these processes.
AB - Natural killer (NK) cells are innate effector lymphocytes necessary for defence against stressed, microbe-infected, or malignant cells. NK cells kill target cells by either of two major mechanisms that require direct contact between NK cells and target cells. In the first pathway, cytoplasmic granule toxins, predominantly a membrane-disrupting protein known as perforin, and a family of structurally related serine proteases (granzymes) with various substrate specificities, are secreted by exocytosis and together induce apoptosis of the target cell. The granule-exocytosis pathway potently activates cell-death mechanisms that operate through the activation of apoptotic cysteine proteases (caspases), but can also cause cell death in the absence of activated caspases. The second pathway involves the engagement of death receptors (e.g. Fas/CD95) on target cells by their cognate ligands (e.g. FasL) on NK cells, resulting in classical caspase-dependent apoptosis. The comparative role of these pathways in the pathophysiology of many diseases is being dissected by analyses of gene-targeted mice that lack these molecules, and humans who have genetic mutations affecting these pathways. We are also now learning that the effector function of NK cells is controlled by interactions involving specific NK cell receptors and their cognate ligands, either on target cells, or other cells of the immune system. This review will discuss the functional importance of NK cell cytotoxicity and the receptor/ligand interactions that control these processes.
KW - Apoptosis
KW - Effector
KW - Receptor
KW - Tumor
KW - Virus
UR - http://www.scopus.com/inward/record.url?scp=10644253717&partnerID=8YFLogxK
U2 - 10.1016/j.molimm.2004.07.034
DO - 10.1016/j.molimm.2004.07.034
M3 - 簡易調査
AN - SCOPUS:10644253717
SN - 0161-5890
VL - 42
SP - 501
EP - 510
JO - Molecular Immunology
JF - Molecular Immunology
IS - 4 SPEC. ISS.
ER -